Article
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa.
Molecular therapy : the journal of the American Society of Gene Therapy - 3 Aug 2022
Bischof Johannes, March Oliver Patrick, Liemberger Bernadette, Haas Simone Alexandra, Hainzl Stefan, Petković Igor, Leb-Reichl Victoria, Illmer Julia, Korotchenko Evgeniia, Klausegger Alfred, Hoog Anna, Binder Heide-Marie, Garcia Marta, Duarte Blanca, Strunk Dirk, Larcher Fernando, Reichelt Julia, Guttmann-Gruber Christina, Wally Verena, Hofbauer Josefina Piñón, Bauer Johann Wolfgang, Cathomen Toni, Kocher Thomas, Koller Ulrich
Abstract excerpt
Junctional epidermolysis bullosa (JEB) is a debilitating hereditary skin disorder caused by mutations in genes encoding laminin-332, type XVII collagen (C17), and integrin-α6β4, which maintain stability between the dermis and epidermis. We designed patient-specific Cas9-nuclease- and -nickase-based targeting strategies for reframing a common homozygous deletion in exon 52 of COL17A1 associated with a lack of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
